Why the study?
Does cardiovascular pre-participation screening prevent sudden cardiac death in young competitive athletes?
Does cardiovascular pre-participation screening prevent sudden cardiac death in young competitive athletes?
Pre-participation cardiovascular screening, particularly with ECG, may be a cost-effective strategy to prevent sudden cardiac death in young athletes, though implementation in Canada faces infrastructure challenges.
May support ECG-inclusive athlete screening; leaves open prospective validation and Canadian infrastructure needs.
This commentary discusses pre-participation cardiovascular screening for young competitive athletes. Canada currently does not have a consolidated document of guidelines for such screening procedure, even though athletes with pre-existing cardiovascular conditions may experience sudden cardiac death (SCD) during intensive training or competitions. How can we balance the safety of athletes while considering the costs of implementing such program and the downstream effects of athletes who may be barred from pursuing their dream sport upon diagnosis? This commentary examines the common causes of SCD, components of the screening procedure, costbenefit analyses of pre-participation screening, and management strategies upon diagnosis.
No takes yet. Share an insight, caveat, or question.
Law-Vinh et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: